Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus
Group A Streptococcus (GAS; Streptococcus pyogenes) is a nearly ubiquitous human pathogen responsible for a significant global disease burden. No vaccine exists, so antibiotics are essential for effective treatment. Despite a lower incidence of antimicrobial resistance than many pathogens, GAS is st...
Guardado en:
Autores principales: | Anders F. Johnson, Christopher N. LaRock |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bdd1697612784a05906329b61516774a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Problemas de resistencia en Streptococcus pyogenes
por: Camponovo C.,Rossanna
Publicado: (2002) -
The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
por: Jeffrey A. Freiberg, et al.
Publicado: (2020) -
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
por: Lisa Bohlmann, et al.
Publicado: (2018) -
An Experimental Group A <italic toggle="yes">Streptococcus</italic> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
por: Tania Rivera-Hernandez, et al.
Publicado: (2019) -
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
por: Sanaz Salehi, et al.
Publicado: (2018)